Umbilical Cord Blood Infusion

BIOLOGICAL5 trials

Conditions

Anemia, NeonatalBronchopulmonary DysplasiaCerebral PalsyErythropoietinIntracranial HemorrhagesNecrotizing EnterocolitisRespiratory Distress Syndrome, NewbornRetinopathy of Prematurity

Phase 1

Autologous Cord Blood Infusion for the Prevention and Treatment of Prematurity Complications In Preterm Neonates

NCT02050971

Pomeranian Medical University SzczecinAnemia, Neonatal, Bronchopulmonary Dysplasia, Intracranial Hemorrhages +3

Start: 2010-10-31End: 2015-12-31Target: 40Updated: 2014-01-31

Combination Therapy of Umbilical Cord Blood and Erythropoietin for Stroke Paients

NCT04013646

Bundang CHA HospitalErythropoietin, Safety, Stroke +2

Start: 2019-05-02End: 2021-11-02Target: 24Updated: 2020-11-05

Phase 2

FLT-PET Activity Change After Allogeneic Umbilical Cord Blood (UCB) Therapy in Cerebral Palsy

WithdrawnNCT01486732

Bundang CHA HospitalCerebral Palsy

Start: 2013-03-31End: 2014-07-31Updated: 2013-11-19

Umbilical Cord Blood Therapy for Cerebral Palsy

CompletedNCT01528436

MinYoung Kim, M.D.Cerebral Palsy

Start: 2012-02-29End: 2012-07-31Updated: 2012-07-18

Unknown Phase

Allogenic Umbilical Cord Blood and Erythropoietin Combination Therapy for Cerebral Palsy

CompletedNCT01193660

Sung Kwang Medical FoundationCerebral Palsy

Start: 2010-05-31End: 2011-04-30Updated: 2020-11-24

Related Papers

Safety and efficacy of allogeneic umbilical cord blood cells and erythropoietin combination therapy in patients with subacute stroke.